KYMR logo

Kymera Therapeutics Inc

KYMR

$41.85

+ $10.57 (33.80%) This month

Closed: 23 Feb 2024 21:00 US/Eastern

Key details

CEO

Nello Mainolfi

Employees

180

Headquarters

Watertown, US

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About Kymera Therapeutics Inc

kymera therapeutics is pioneering a transformative new approach to treating previously untreatable diseases. we are advancing the field of targeted protein degradation, accessing the body’s innate protein recycling machinery to degrade rather than inhibit dysregulated, disease-causing proteins. powered by a proprietary predictive modeling capability and a game-changing integrated degradation platform with a novel small molecule modality, our company is committed to accelerating drug discovery with an unmatched ability to target and degrade the most intractable of proteins, and advance new treatment options for patients. learn more at kymeratx.com.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG